Dosing & Administration
This unit explains, for education only, the Russian-registered dosing and the community intranasal practices you will r…
What the label says, and why the brain sees less
This unit explains, for education only, the Russian-registered dosing and the community intranasal practices you will read about, so you can interpret them critically. It is not a protocol, a dose, or a recommendation, and Selank is not approved for use in the United States.
The honest throughline is intranasal variability: the dose on the vial is not the dose at the brain, and spray devices, technique, and product quality make "precise" nasal dosing something of an illusion.
Key terms
The Russian-registered protocol
The clearest reference point is the Russian-registered regimen, presented here as regulatory information, not a prescription. Note first what the registration document actually contains: a strength and a schedule, not a microgram dose. The 0.15% solution is 1.5 mg/mL, and the instruction is 2 drops in each nostril three times daily for 14 days, repeatable after 1 to 3 weeks and only after consulting a doctor. Every microgram figure below is arithmetic laid on top of that. Take a nasal drop as roughly 0.05 mL, a common working assumption rather than a label figure, and 4 drops works out to about 300 micrograms per administration. The anxiety protocol is a defined short course rather than open-ended daily use.
Two features deserve emphasis. First, the regimen is a course: about 14 days, then reassessment, not a permanent daily habit. Second, these are Russian pharmaceutical figures for a quality-controlled product; they do not transfer cleanly to an unregulated US research-peptide vial of uncertain concentration. The number is a reference, not an instruction.
This unit is education only and not medical advice. The Russian regimen is regulatory reference information, not a recommendation to use Selank.